SHPRH and breast carcinoma: Down regulation of RAD5, sensitization to radiotherapy; suppression of breast cancer proliferation via linc00339/miR-4656/CSNK2B signaling pathway and by inhibition of cyclin B1 expression, promoting G2/M-phase arrest and modulating the PI3K/AKT signaling pathway